VASTERA
Bastera is a biotech company with the primary goal of developing groundbreaking treatments for cardiovascular and cancer diseases. Their approach involves targeting new redox signaling pathways, aiming to pioneer "first-in-class" therapies in these fields. Vastera was established in 2018 when SangWon Kang, a professor at Ewha Womans University, transferred a patent based on research results on redox signaling in blood vessels and cancer.
VASTERA
Industry:
Biotechnology Health Care Life Science
Founded:
2018-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.vasthera.com
Total Employee:
11+
Status:
Active
Total Funding:
23.5 B KRW
Technology used in webpage:
Euro SPF Microsoft Exchange Online Office 365 Mail Pound Sterling Microsoft Azure DNS Japanese Yen SK Broadband
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโbased treatments for cardiovascular disease.
Investors List
Daesung Private Equity
Daesung Private Equity investment in Series B - Vastera
Medytox Venture Investment
Medytox Venture Investment investment in Series B - Vastera
ID ventures
ID ventures investment in Series B - Vastera
SJ Investment Partners
SJ Investment Partners investment in Series B - Vastera
Partners Investment
Partners Investment investment in Series B - Vastera
Shinhan Venture Investment
Shinhan Venture Investment investment in Series B - Vastera
Medici Investment
Medici Investment investment in Series B - Vastera
UTC Investment Co.
UTC Investment Co. investment in Series B - Vastera
Premier Partners
Premier Partners investment in Venture Round - Vastera
Official Site Inspections
http://www.vasthera.com
- Host name: swpni.co.kr
- IP address: 58.229.176.26
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Vastera"
VasThera
Build up the pipelines for developing the first-in-class synthetic therapeutics mimicking the PRX enzyme that controls the growth of vascular cells.See details»
VaxThera - Crunchbase Company Profile & Funding
VaxThera provides a production and research plants for biological products. They develop vaccines and medicines for the prevention and treatment of infectious diseases and other โฆSee details»
VaxThera, a SURA Company Created in Colombia for the
Jun 29, 2021 Aware of this situation, and looking to protect life, Seguros SURA has decided to invest in the creation of VaxThera, because this organization will allow us to move forward in โฆSee details»
VaxThera, a SURA Company Created in Colombia for the
Jun 30, 2021 VaxThera is a Colombian company focused on science, dedicated to the research and development of biological products for the world. The Company seeks to generate health โฆSee details»
VaxThera, a SURA Company Created in Colombia for โฆ
Jun 30, 2021 Aware of this situation, and looking to protect life, Seguros SURA has decided to invest in the creation of VaxThera, because this organization will allow us to move forward in biotechnology, as ...See details»
VaxThera, a SURA company, inaugurated its โฆ
May 15, 2024 In addition to being a relevant milestone for public health and health sovereignty in Colombia, it is indeed an example of how a balanced capital management allows for โฆSee details»
VASTHERA
A Korea-based innovative pharmaceutical company pioneering first-in-class drugs for chronic inflammatory diseases, such as cardiovascular, cancer, eye, and neurodegenerative diseases.See details»
VaxThera - Org Chart, Teams, Culture & Jobs | The Org
View VaxThera's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Independence of Biologicals for Colombia: Why is it historically ...
About VaxThera VaxThera is a Colombian science-based company dedicated to research and development of biologicals for the world. The company aims to achieve sanitary independence โฆSee details»
VaxThera - Contacts, Employees, Board Members, Advisors & Alumni
VaxThera develops and produces vaccines to prevents and treats diseases.See details»
VaxThera, Seguros SURA Colombiaโs new biotechnological โฆ
Jun 10, 2022 The Company seeks to create greater health care independence through research, development and innovation in biotechnology and health. VaxThera came into being thanks to โฆSee details»
Providence Therapeutics Holdings Inc., VaxThera S.A.S, and
Dec 17, 2021 About VaxThera VaxThera is a Colombian company focused on science, dedicated to the research and development of biological products for the world.See details»
VaxThera, a SURA Company Created in Colombia for the Research โฆ
Jun 30, 2021 VaxThera is a company focused on science, where biologicals will be researched and developed from Colombia for the world, looking to meet Latin America's need of vaccine โฆSee details»
Vasthera - Company Profile - Tracxn
Jan 16, 2025 Vasthera - Developer of synthetic therapeutic solutions for vascular hyperplasia. Raised funding from 4 investors. Founded by SangWon Kang in the year 2017. Vasthera has โฆSee details»
VaxThera, the vaccine โMade in Colombiaโ is a reality and marks a ...
May 16, 2024 The inauguration of the VaxThera plant promises to strengthen health sovereignty and boost biotechnology research in Latin America.See details»
VASTHERA - VentureRadar
Develops first-in-class synthetic therapeutics targeting vascular hyperplasia, focusing on pulmonary arterial hypertension treatment and expanding to other arterial diseases, utilizing โฆSee details»
Work with us - Vaxthera
At VaxThera, we aim to provide hope, health, and life through science and technology. Our team consists of outstanding professionals, but above all, exceptional individuals.See details»
Vasthera's solution to Alzheimer's disease - YouTube
Sep 26, 2024 This video explains the mechanism of action of VTA-27, Vasthera's first-in-class, disease-modifying drug for Alzheimerโs diseaseSee details»
VaxThera Obtains Patent for a Universal Vaccine Against COVID-19 ...
The United States Patent and Trademark Office (USPTO) has granted our client VaxThera, a Colombian biotechnology company, a patent for its universal vaccine against the COVID-19 โฆSee details»
VASTHERA
As of this year, there are a total of 127 drugs to treat Alzheimer's disease, of which 18% (23) are targeted for Aฮฒ.However, a growing number of bio companies are accelerating research and โฆSee details»